$BIGC
BigCommerce Holdings, Inc. Stock $bigc

$bigc Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000095017023005598 Filed on March 01, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$71.76M	$72.43M	$279.1M
YoY Change	8.64%	11.61%	26.94%
Cost Of Revenue	$17.45M	$18.49M	$69.98M
YoY Change	2.01%	11.12%	44.35%
Gross Profit	$54.31M	$53.94M	$209.1M
YoY Change	10.96%	11.78%	22.01%
Gross Profit Margin	75.69%	74.47%	74.92%
Selling, General & Admin	$50.55M	$52.83M	$210.8M
YoY Change	4.25%	9.99%	34.95%
% of Gross Profit	93.07%	97.95%	100.81%
Research & Development	$20.85M	$22.67M	$88.25M
YoY Change	-0.47%	14.75%	36.73%
% of Gross Profit	38.38%	42.03%	42.21%
Depreciation & Amortization	$2.904M	$2.791M	$3.300M
YoY Change	2.76%	6.12%	17.86%
% of Gross Profit	5.35%	5.17%	1.58%
Operating Expenses	$77.97M	$77.52M	$349.7M
YoY Change	-8.41%	11.26%	41.38%
Operating Profit	-$23.66M	-$23.58M	-$140.6M
YoY Change	-34.61%	10.11%	85.1%
Interest Expense	$722.0K	$1.360M	$2.828M
YoY Change	-223.0%	-313.17%	-505.16%
% of Operating Profit
Other Income/Expense, Net	$31.00K	$601.0K	-$227.0K
YoY Change	-119.87%	-782.95%	224.29%
Pretax Income	-$21.92M	-$32.73M	-$139.4M
YoY Change	-40.62%	-5.25%	81.75%
Income Tax	$197.0K	$254.0K	$495.0K
% Of Pretax Income
Net Earnings	-$22.12M	-$32.98M	-$139.9M
YoY Change	-40.28%	-3.69%	82.48%
Net Earnings / Revenue	-30.83%	-45.53%	-50.14%
Basic Earnings Per Share	-$0.30		-$1.91
Diluted Earnings Per Share	-$0.30	-$0.45	-$1.91
COMMON SHARES
Basic Shares Outstanding	74.12M		73.23M
Diluted Shares Outstanding	74.14M		73.23M

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$282.3M	$303.5M	$303.5M
YoY Change	-24.93%	-24.1%	-24.1%
Cash & Equivalents	$61.07M	$91.57M	$91.57M
Short-Term Investments	$221.3M	$211.9M	$211.9M
Other Short-Term Assets	$21.60M	$18.83M	$18.83M
YoY Change	33.82%	26.69%	26.69%
Inventory
Prepaid Expenses
Receivables	$59.01M	$51.90M	$51.90M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$362.9M	$374.2M	$374.2M
YoY Change	-16.23%	-17.67%	-17.67%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.25M	$9.083M	$14.97M
YoY Change	28.46%	22.26%	-11.65%
Goodwill	$49.75M	$49.75M
YoY Change		17.24%
Intangibles	$25.55M	$27.58M
YoY Change		-21.26%
Long-Term Investments
YoY Change
Other Assets	$7.614M	$7.507M	$7.507M
YoY Change	13.47%	15.42%	15.42%
Total Long-Term Assets	$98.56M	$99.81M	$99.81M
YoY Change	-3.15%	-1.09%	-1.09%
TOTAL ASSETS
Total Short-Term Assets	$362.9M	$374.2M	$374.2M
Total Long-Term Assets	$98.56M	$99.81M	$99.81M
Total Assets	$461.5M	$474.1M	$474.1M
YoY Change	-13.74%	-14.66%	-14.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.508M	$7.013M	$7.013M
YoY Change	-5.25%	-14.59%	-14.59%
Accrued Expenses	$4.239M	$2.937M	$49.08M
YoY Change	-89.56%	-0.14%	29.5%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$77.36M	$78.79M	$78.79M
YoY Change	19.37%	25.43%	25.43%
LONG-TERM LIABILITIES
Long-Term Debt	$338.0M	$337.5M	$337.5M
YoY Change	0.58%	0.58%	0.58%
Other Long-Term Liabilities	$478.0K	$334.0K	$12.10M
YoY Change	-98.03%	-95.39%	-35.72%
Total Long-Term Liabilities	$338.5M	$337.8M	$349.6M
YoY Change	0.73%	-1.45%	-1.34%
TOTAL LIABILITIES
Total Short-Term Liabilities	$77.36M	$78.79M	$78.79M
Total Long-Term Liabilities	$338.5M	$337.8M	$349.6M
Total Liabilities	$427.1M	$428.4M	$428.4M
YoY Change	0.45%	2.69%	2.69%
SHAREHOLDERS EQUITY
Retained Earnings	-$552.1M	-$530.0M
YoY Change		35.87%
Common Stock	$587.0M	$576.9M
YoY Change		9.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$34.44M	$45.67M	$45.67M
YoY Change
Total Liabilities & Shareholders Equity	$461.5M	$474.1M	$474.1M
YoY Change	-13.74%	-14.66%	-14.66%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$22.12M	-$32.98M	-$139.9M
YoY Change	-40.28%	-3.69%	82.48%
Depreciation, Depletion And Amortization	$2.904M	$2.791M	$3.300M
YoY Change	2.76%	6.12%	17.86%
Cash From Operating Activities	-$20.84M	-$2.693M	-$89.36M
YoY Change	-5.23%	-69.46%	121.73%
INVESTING ACTIVITIES
Capital Expenditures	$1.063M	$990.0K	$5.196M
YoY Change	-179.33%	-197.35%	-257.26%
Acquisitions
YoY Change
Other Investing Activities	-$8.614M	-$5.397M	-$111.3M
YoY Change	-63.3%	-90.88%	-39.35%
Cash From Investing Activities	-$9.677M	-$6.387M	-$116.5M
YoY Change	-61.0%	-89.39%	-37.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-330.0K	145.0K	209.0K
YoY Change	-279.35%	-91.17%	-99.93%
NET CHANGE
Cash From Operating Activities	-20.84M	-2.693M	-89.36M
Cash From Investing Activities	-9.677M	-6.387M	-116.5M
Cash From Financing Activities	-330.0K	145.0K	209.0K
Net Change In Cash	-30.84M	-8.935M	-205.7M
YoY Change	-33.83%	-86.73%	-363.36%
FREE CASH FLOW
Cash From Operating Activities	-$20.84M	-$2.693M	-$89.36M
Capital Expenditures	$1.063M	$990.0K	$5.196M
Free Cash Flow	-$21.90M	-$3.683M	-$94.55M
YoY Change	6.07%	-52.78%	155.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2013-02-28
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022	us-gaap	Income Tax Examination Year Under Examination IncomeTaxExaminationYearUnderExamination	2018 2019 2020 2021
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001626450
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-39423
CY2022	dei	Entity Registrant Name EntityRegistrantName	BigCommerce Holdings, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-2707656
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	11305 Four Points DriveBuilding II, Suite 100
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Austin
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	78726
CY2022	dei	City Area Code CityAreaCode	512
CY2022	dei	Local Phone Number LocalPhoneNumber	865-4500
CY2022	dei	Security12b Title Security12bTitle	Series 1 common stock, $0.0001 par value per share
CY2022	dei	Trading Symbol TradingSymbol	BIGC
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	1080000000.00
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	74121451
CY2022	dei	Auditor Firm AuditorFirmId	42
CY2022	dei	Auditor Name AuditorName	Ernst and Young LLP
CY2022	dei	Auditor Location AuditorLocation	Austin, TX
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	91573000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	297561000
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1457000
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1143000
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	211941000
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	102315000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	51899000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	39806000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11206000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9710000
CY2022Q4	bigc	Deferred Commissions Current DeferredCommissionsCurrent	6171000
CY2021Q4	bigc	Deferred Commissions Current DeferredCommissionsCurrent	4013000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	374247000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	454548000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9083000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7429000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5887000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9515000
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	470000
CY2021Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	831000
CY2022Q4	bigc	Deferred Commissions Noncurrent DeferredCommissionsNoncurrent	7037000
CY2021Q4	bigc	Deferred Commissions Noncurrent DeferredCommissionsNoncurrent	5673000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	27583000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	35032000
CY2022Q4	us-gaap	Goodwill Goodwill	49749000
CY2021Q4	us-gaap	Goodwill Goodwill	42432000
CY2022Q4	us-gaap	Assets Assets	474056000
CY2021Q4	us-gaap	Assets Assets	555460000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7013000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8211000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2937000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2941000
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	17783000
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	12752000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2609000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	78786000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	62811000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2653000
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	48444000
CY2021Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1359000
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	36254000
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	337497000
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	335537000
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1759000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	10008000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	10217000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	334000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7248000
CY2022Q4	us-gaap	Liabilities Liabilities	428384000
CY2021Q4	us-gaap	Liabilities Liabilities	417172000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	7000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	7000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	576851000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	528540000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1199000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-191000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-529987000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-390068000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	45672000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	138288000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	474056000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	555460000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	279075000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	219855000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	152368000
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	69980000
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	48479000
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	34126000
CY2022	us-gaap	Gross Profit GrossProfit	209095000
CY2021	us-gaap	Gross Profit GrossProfit	171376000
CY2020	us-gaap	Gross Profit GrossProfit	118242000
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	134794000
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	99350000
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	72470000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	88253000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	64547000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	48332000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	75989000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	56839000
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	36137000
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	35216000
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	23299000
CY2022	us-gaap	Restructuring Charges RestructuringCharges	7332000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8078000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3284000
CY2022	us-gaap	Operating Expenses OperatingExpenses	349662000
CY2021	us-gaap	Operating Expenses OperatingExpenses	247319000
CY2020	us-gaap	Operating Expenses OperatingExpenses	156939000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-140567000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-75943000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-38697000
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	4198000
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	130000
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	31000
CY2022	us-gaap	Interest Expense InterestExpense	2828000
CY2021	us-gaap	Interest Expense InterestExpense	828000
CY2020	us-gaap	Interest Expense InterestExpense	3103000
CY2020	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	4413000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-227000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-70000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-179000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-139424000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-76711000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-37535000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	495000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-34000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	25000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-139919000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-76677000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-37560000
CY2020	bigc	Dividends And Accretion Of Issuance Costs DividendsAndAccretionOfIssuanceCosts	962000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-139919000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-76677000
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-38522000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.91
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.91
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.08
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.08
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.99
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.99
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	73226000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	73226000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	70933000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	70933000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39092000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39092000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-139919000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-76677000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-37560000
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1008000
CY2021	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-191000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-140927000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-76868000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-37560000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-257303000
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3151000
CY2020	bigc	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	126000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11058000
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	171129000
CY2020	bigc	Stock Issued During Period Value Secondary Public Offering Issues StockIssuedDuringPeriodValueSecondaryPublicOfferingIssues	65112000
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	211902000
CY2020	bigc	Stock Issued During Period Value Conversion Of Convertible Debt Securities StockIssuedDuringPeriodValueConversionOfConvertibleDebtSecurities	50173000
CY2020	bigc	Changes In Preferred Stock Dividends ChangesInPreferredStockDividends	918000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	44000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	297000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-37560000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	216759000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6540000
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	2003000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	25424000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	-35570000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-191000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-76677000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	138288000
CY2022	bigc	Stock Issued During Period Value Stock Options Exercise Net Of Shares Withheld For Taxes StockIssuedDuringPeriodValueStockOptionsExerciseNetOfSharesWithheldForTaxes	436000
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	5543000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	42332000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1008000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-139919000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	45672000
CY2022	us-gaap	Profit Loss ProfitLoss	-139919000
CY2021	us-gaap	Profit Loss ProfitLoss	-76677000
CY2020	us-gaap	Profit Loss ProfitLoss	-37560000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11421000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6151000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3084000
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1960000
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	574000
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	774000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	42332000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	25424000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	11058000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	8244000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3474000
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1594000
CY2020	us-gaap	Increase Decrease In Financial Instruments Used In Operating Activities IncreaseDecreaseInFinancialInstrumentsUsedInOperatingActivities	4413000
CY2022	us-gaap	Restructuring Charges RestructuringCharges	7332000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	20337000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	17279000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9305000
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1134000
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	2413000
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	2704000
CY2022	bigc	Increase Decrease In Deferred Commissions IncreaseDecreaseInDeferredCommissions	3463000
CY2021	bigc	Increase Decrease In Deferred Commissions IncreaseDecreaseInDeferredCommissions	3525000
CY2020	bigc	Increase Decrease In Deferred Commissions IncreaseDecreaseInDeferredCommissions	2396000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1198000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2137000
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1907000
CY2022	bigc	Increase Decrease In Accrued And Other Current Liabilities IncreaseDecreaseInAccruedAndOtherCurrentLiabilities	100000
CY2021	bigc	Increase Decrease In Accrued And Other Current Liabilities IncreaseDecreaseInAccruedAndOtherCurrentLiabilities	20437000
CY2020	bigc	Increase Decrease In Accrued And Other Current Liabilities IncreaseDecreaseInAccruedAndOtherCurrentLiabilities	9610000
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	5305000
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1397000
CY2020	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1822000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-89357000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-40300000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26529000
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	696000
CY2021	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	81067000
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	214184000
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	107006000
CY2022	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	5196000
CY2021	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	3304000
CY2020	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	1964000
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	103550000
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	4500000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-116526000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-186877000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1964000
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	10037000
CY2021	bigc	Purchase Of Capped Calls PurchaseOfCappedCalls	-35570000
CY2020	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	171129000
CY2020	bigc	Proceeds From Issuance Secondary Public Offering ProceedsFromIssuanceSecondaryPublicOffering	65112000
CY2020	us-gaap	Payments Of Dividends PaymentsOfDividends	12814000
CY2022	bigc	Proceeds From Exercise Of Stock Options And Warrants ProceedsFromExerciseOfStockOptionsAndWarrants	209000
CY2021	bigc	Proceeds From Exercise Of Stock Options And Warrants ProceedsFromExerciseOfStockOptionsAndWarrants	5881000
CY2020	bigc	Proceeds From Exercise Of Stock Options And Warrants ProceedsFromExerciseOfStockOptionsAndWarrants	3279000
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	345000000
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	41861000
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	28617000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	209000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	305274000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	239950000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-205674000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	78097000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	211457000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	298704000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	220607000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9150000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	93030000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	298704000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	220607000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	903000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	2285000
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	32000
CY2022	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	5388000
CY2021	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	2003000
CY2020	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	211902000
CY2020	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	50173000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	91573000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	297561000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	219447000
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1457000
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1143000
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1160000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	93030000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	298704000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	220607000
CY2022Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	4914000
CY2021Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	3951000
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Use of estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The preparation of consolidated financial statements in conformity with GAAP requires certain financial instruments to be recorded at fair value; requires our management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenue and expenses during the reporting periods. Significant estimates, judgments, and assumptions in these consolidated financial statements include: allocating variable consideration for revenue recognition, constrained revenue; the amortization period for deferred commissions; the allowance for credit losses and a determination of the deferred tax asset valuation allowance. Because of the use of estimates inherent in financial reporting process actual results could differ and the differences could be material to our consolidated financial statements</span></p>
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	279075000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	219855000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	152368000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9083000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7429000
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	19900000
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	13100000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1167000
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1594000
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1133000
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1992000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3474000
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1599000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3867000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	8244000
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	2116000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	9995000
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	2800000
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	1700000
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Concentration of credit risks, significant clients, and suppliers</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Financial instruments that potentially subject us to concentrations of credit risk consist of cash and cash equivalents, restricted cash, and accounts receivable. Our investment policy limits investments to high credit quality securities issued by the U.S. government, U.S. government-sponsored agencies, and highly rated corporate securities, subject to certain concentration limits and restrictions on maturities. Our cash and cash equivalents and restricted cash are held by financial institutions that management believes are of high credit quality. Amounts on deposit may at times exceed federally insured limits. We have not experienced any losses on our deposits of cash and cash equivalents. We are exposed to credit risk in the event of default by the financial institutions holding our cash and cash equivalents and bond issuers.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Accounts receivable, including unbilled amounts, are derived from sales to our customers and our strategic technology partners who operate in a variety of sectors. We do not require collateral. Estimated credit losses are provided for in the consolidated financial statements and historically have been within management’s expectations.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">One</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> of our strategic partners accou</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">nted for </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">12</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">%, </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">14</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">% and </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">15</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">% of our revenue at December 31, 2022, 2021 and 2020, respectively, and two of our strategic partners accounted</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> for </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">30</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">% at December 31, 2022 while only one strategic partner accounted for </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">19</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">% and</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">24</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">% of our accounts receivable balance at December 31, 2021 and 2020, respectively.</span></p>
CY2020	bigc	Concentration Risk Number Of Customer ConcentrationRiskNumberOfCustomer	1
CY2022	bigc	Concentration Risk Number Of Customer ConcentrationRiskNumberOfCustomer	1
CY2021	bigc	Concentration Risk Number Of Customer ConcentrationRiskNumberOfCustomer	1
CY2022	us-gaap	Advertising Expense AdvertisingExpense	17500000
CY2021	us-gaap	Advertising Expense AdvertisingExpense	16800000
CY2020	us-gaap	Advertising Expense AdvertisingExpense	12900000
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	3700000
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	35200000
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	23300000
CY2020	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0.0
CY2022	bigc	Business Combination Acquisition Related Spend BusinessCombinationAcquisitionRelatedSpend	200000
CY2022	bigc	Business Combination Compensation Expense Related To Contingent Compensation BusinessCombinationCompensationExpenseRelatedToContingentCompensation	5000000.0
CY2021	bigc	Business Combination Acquisition Related Spend BusinessCombinationAcquisitionRelatedSpend	1800000
CY2021	bigc	Business Combination Compensation Expense Related To Contingent Compensation BusinessCombinationCompensationExpenseRelatedToContingentCompensation	21500000
CY2022	bigc	First Contingent Compensation Arrangement Payments Over Service Period FirstContingentCompensationArrangementPaymentsOverServicePeriod	P12M
CY2022	bigc	Second Contingent Compensation Arrangement Payments Over Service Period SecondContingentCompensationArrangementPaymentsOverServicePeriod	P24M
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	279075000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	219855000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	152368000
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	12000000.0
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	166100000
CY2022	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation	We expect to recognize approximately 51% of the remaining performance obligations as revenue in the next 12 months, and the remaining balance in the periods thereafter.
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.51
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2022	bigc	Amortization Of Deferred Sales Commissions Estimated Period AmortizationOfDeferredSalesCommissionsEstimatedPeriod	P4Y
CY2022	bigc	Impairment Of Deferred Commissions ImpairmentOfDeferredCommissions	0
CY2021	bigc	Impairment Of Deferred Commissions ImpairmentOfDeferredCommissions	0
CY2020	bigc	Impairment Of Deferred Commissions ImpairmentOfDeferredCommissions	0
CY2022Q4	bigc	Deferred Sales Commissions DeferredSalesCommissions	8900000
CY2021Q4	bigc	Deferred Sales Commissions DeferredSalesCommissions	7000000.0
CY2020Q4	bigc	Deferred Sales Commissions DeferredSalesCommissions	4500000
CY2022	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	5200000
CY2021	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	3500000
CY2020	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	2200000
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	280070000
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	364994000
CY2021Q3	bigc	Business Combinations Existing Products And Financial Milestones BusinessCombinationsExistingProductsAndFinancialMilestones	65000000.0
CY2022	bigc	First Contingent Compensation Arrangement Payments Over Service Period FirstContingentCompensationArrangementPaymentsOverServicePeriod	P12M
CY2022	bigc	Second Contingent Compensation Arrangement Payments Over Service Period SecondContingentCompensationArrangementPaymentsOverServicePeriod	P24M
CY2022Q3	bigc	Business Combination Contingent Compensation BusinessCombinationContingentCompensation	32500000
CY2021Q4	us-gaap	Goodwill Goodwill	42432000
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	7317000
CY2022Q4	us-gaap	Goodwill Goodwill	49749000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	8100000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3300000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0.0
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	39009000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11426000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	27583000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	38379000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3347000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	35032000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	8132000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	7997000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	6308000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3429000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1717000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	27583000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25223000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20210000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16140000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12781000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9083000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7429000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3300000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2800000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3100000
CY2022Q4	us-gaap	Recorded Unconditional Purchase Obligation Due Within One Year RecordedUnconditionalPurchaseObligationDueWithinOneYear	11359000
CY2022Q4	us-gaap	Recorded Unconditional Purchase Obligation Due In Second Year RecordedUnconditionalPurchaseObligationDueInSecondYear	10750000
CY2022Q4	us-gaap	Recorded Unconditional Purchase Obligation Due In Third Year RecordedUnconditionalPurchaseObligationDueInThirdYear	8625000
CY2022Q4	us-gaap	Recorded Unconditional Purchase Obligation RecordedUnconditionalPurchaseObligation	30734000
CY2021Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0
CY2022Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0
CY2022	bigc	Lease Operating Lease Expiration Year LeaseOperatingLeaseExpirationYear	2028
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	3900000
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	3800000
CY2022	bigc	Operating Lease Short Term Rent Expense OperatingLeaseShortTermRentExpense	500000
CY2021	bigc	Operating Lease Short Term Rent Expense OperatingLeaseShortTermRentExpense	500000
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	3700000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	3807000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	3927000
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y2M12D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y6M
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0537
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0546
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3254000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2985000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2775000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2528000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	2133000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	718000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	14393000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1715000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	12678000
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1887000
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	679000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	16900000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	17315000
CY2022Q4	bigc	Acquisition Related Compensation Current AcquisitionRelatedCompensationCurrent	24743000
CY2021Q4	bigc	Acquisition Related Compensation Current AcquisitionRelatedCompensationCurrent	14309000
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	48444000
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	36254000
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	345000000
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	345000000
CY2022Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	7503000
CY2021Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	9463000
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	337497000
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	335537000
CY2022	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	7500000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	11.79
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	30.71
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.01
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8215000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.30
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y7M24D
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	491648000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	263000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	58.36
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2426000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.46
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	324000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	11.22
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5728000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.77
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y11M12D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	168772000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	893000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	20.04
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	729000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	3.01
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	167000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	16.91
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5725000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.33
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y6M
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	23331000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	5558000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	8.96
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y5M4D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	23294000
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	4237000
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	5.36
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y9M21D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	22462000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	11400000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	126000000.0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	72400000
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	7200000
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	6400000
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	11400000
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	13100000
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	11500000
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	11400000
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y6M
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1408000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	24.67
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1548000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	57.19
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	350000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	24.07
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	234000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	42.97
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2372000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	44.10
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	4880000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	16.44
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	634000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	32.95
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	403000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	46.57
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	61000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-202000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	6215000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	23.53
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	42332000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	25424000
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11058000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-118579000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-62558000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-31891000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-20845000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-14153000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-5644000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-139424000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-76711000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-37535000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	27000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	11000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	24000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	261000
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	134000
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	288000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	145000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	25000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	146000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	23000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	207000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-179000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	495000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-34000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	25000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0533
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0558
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0491
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.0064
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.0083
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.0066
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.0080
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.0265
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.0497
CY2022	bigc	Effective Income Tax Rate Reconciliation Purchase Price Accounting EffectiveIncomeTaxRateReconciliationPurchasePriceAccounting	0.0009
CY2021	bigc	Effective Income Tax Rate Reconciliation Purchase Price Accounting EffectiveIncomeTaxRateReconciliationPurchasePriceAccounting	0.0035
CY2020	bigc	Effective Income Tax Rate Reconciliation Purchase Price Accounting EffectiveIncomeTaxRateReconciliationPurchasePriceAccounting	0.0000
CY2022	bigc	Effective Income Tax Rate Reconciliation Excess Tax Benefits Relating To Stock Based Compensation EffectiveIncomeTaxRateReconciliationExcessTaxBenefitsRelatingToStockBasedCompensation	-0.0116
CY2021	bigc	Effective Income Tax Rate Reconciliation Excess Tax Benefits Relating To Stock Based Compensation EffectiveIncomeTaxRateReconciliationExcessTaxBenefitsRelatingToStockBasedCompensation	0.2629
CY2020	bigc	Effective Income Tax Rate Reconciliation Excess Tax Benefits Relating To Stock Based Compensation EffectiveIncomeTaxRateReconciliationExcessTaxBenefitsRelatingToStockBasedCompensation	0.1697
CY2022	bigc	Effective Income Tax Rate Reconciliation Officers Compensation EffectiveIncomeTaxRateReconciliationOfficersCompensation	-0.0059
CY2021	bigc	Effective Income Tax Rate Reconciliation Officers Compensation EffectiveIncomeTaxRateReconciliationOfficersCompensation	-0.1565
CY2020	bigc	Effective Income Tax Rate Reconciliation Officers Compensation EffectiveIncomeTaxRateReconciliationOfficersCompensation	0.0000
CY2022	bigc	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	-0.0050
CY2021	bigc	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	-0.0092
CY2020	bigc	Effective Income Tax Rate Reconciliation Permanent Differences EffectiveIncomeTaxRateReconciliationPermanentDifferences	-0.0817
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2597
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.4009
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.4041
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0036
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0004
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0007
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	100303000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	76475000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	6969000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	5901000
CY2022Q4	bigc	Deferred Tax Assets Allowance For Credit Losses DeferredTaxAssetsAllowanceForCreditLosses	2614000
CY2021Q4	bigc	Deferred Tax Assets Allowance For Credit Losses DeferredTaxAssetsAllowanceForCreditLosses	956000
CY2022Q4	bigc	Deferred Tax Assets Capitalized Research And Experimental Costs DeferredTaxAssetsCapitalizedResearchAndExperimentalCosts	7501000
CY2022Q4	bigc	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	3145000
CY2021Q4	bigc	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	3176000
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	272000
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	358000
CY2022Q4	bigc	Deferred Tax Assets Depreciation And Amortization DeferredTaxAssetsDepreciationAndAmortization	16261000
CY2021Q4	bigc	Deferred Tax Assets Depreciation And Amortization DeferredTaxAssetsDepreciationAndAmortization	7942000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5776000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3367000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	511000
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	756000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	143352000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	98931000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	136101000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	92531000
CY2022Q4	bigc	Deferred Tax Liabilities Deferred Commissions DeferredTaxLiabilitiesDeferredCommissions	-2632000
CY2021Q4	bigc	Deferred Tax Liabilities Deferred Commissions DeferredTaxLiabilitiesDeferredCommissions	-2022000
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	1474000
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	2338000
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	965000
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	321000
CY2022Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	1739000
CY2021Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	1731000
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	768000
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	82000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	7578000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	6494000
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	327000
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	94000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	294900000
CY2022Q4	bigc	Deferred Tax Assets Operating Loss Carryforwards Domestic Prior Year DeferredTaxAssetsOperatingLossCarryforwardsDomesticPriorYear	246500000
CY2022Q4	bigc	Deferred Tax Assets Operating Loss Carryforwards Domestic To Future Period DeferredTaxAssetsOperatingLossCarryforwardsDomesticToFuturePeriod	48400000
CY2022	bigc	Operating Loss Carryforwards Expiration Year OperatingLossCarryforwardsExpirationYear	2036
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	165600000
CY2022	bigc	Net Operating Loss Carryforwards Expiration Year NetOperatingLossCarryforwardsExpirationYear	2036
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	44200000
CY2022Q4	bigc	Deferred Tax Assets Tax Credit Carryforwards Research And Development Domestic DeferredTaxAssetsTaxCreditCarryforwardsResearchAndDevelopmentDomestic	8800000
CY2022	bigc	Tax Credits Begin To Expiration Year TaxCreditsBeginToExpirationYear	2034
CY2022Q4	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	43600000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	400000
CY2022	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0
CY2021	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	396000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	396000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	396000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	396000
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20297000
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14490000
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9623000

Files In Submission

Name	View Source	Status
bigc-20221231_cal.xml	Edgar Link	unprocessable
0000950170-23-005598-index-headers.html	Edgar Link	pending
0000950170-23-005598-index.html	Edgar Link	pending
0000950170-23-005598.txt	Edgar Link	pending
0000950170-23-005598-xbrl.zip	Edgar Link	pending
bigc-20221231.htm	Edgar Link	pending
bigc-20221231.xsd	Edgar Link	pending
bigc-ex10_25.htm	Edgar Link	pending
bigc-ex21_1.htm	Edgar Link	pending
bigc-ex23_1.htm	Edgar Link	pending
bigc-ex31_1.htm	Edgar Link	pending
bigc-ex31_2.htm	Edgar Link	pending
bigc-ex32_1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img63393127_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
bigc-20221231_def.xml	Edgar Link	unprocessable
bigc-20221231_lab.xml	Edgar Link	unprocessable
bigc-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bigc-20221231_htm.xml	Edgar Link	completed
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BIGC
BigCommerce Holdings, Inc. Stock $bigc

2023 Q1 Form 10-K Financial Statement

#000095017023005598 Filed on March 01, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIGC BigCommerce Holdings, Inc. Stock $bigc

2023 Q1 Form 10-K Financial Statement

#000095017023005598 Filed on March 01, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIGC
BigCommerce Holdings, Inc. Stock $bigc